A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Amenorrhea
Interventions
DRUG

DR-2021a

1 capsule daily for 10 days

DRUG

DR-2021b

1 capsule daily for 10 days

DRUG

DR-2021c

1 capsule daily for 10 days

DRUG

DR-2021d

1 capsule daily for 10 days

DRUG

DR-2021e

1 capsule daily for 10 days

OTHER

Placebo

1 matching placebo capsule for 10 days

Trial Locations (27)

15206

Duramed Investigational Site, Pittsburgh

19090

Duramed Investigational Site, Willow Grove

20707

Duramed Investigational Site, Laurel

23602

Duramed Investigational Site, Newport News

29201

Duramed Investigational Site, Columbia

30134

Duramed Investigational Site, Douglasville

30328

Duramed Investigational Site, Atlanta

30534

Duramed Investigational Ste, Dawsonville

32605

Duramed Investigational Site, Gainesville

33143

Duramed Investigational Site, Miami

34748

Duramed Investigational Site, Leesburg

36608

Duramed Investigational Site, Mobile

38120

Duramed Investigational Site, Memphis

63110

Duramed Investigational Site, St Louis

69301

Duramed Investigational Site, Alliance

75390

Duramed Investigational Site, Dallas

77030

Duramed Investigational Site, Houston

77074

Duramed Investigational Site, Houston

80909

Duramed Investigational Site, Colorado Springs

81001

Duramed Investigational Site, Pueblo

85032

Duramed Investigational Site, Phoenix

85712

Duramed Investigational Site, Tucson

92123

Duramed Investigational Site, San Diego

92130

Duramed Investigational Site, San Diego

95608

Duramed Investigational Site, Carmichael

97505

Duramed Investigational Site, Medford

08648

Duramed Investigational Site, Lawrenceville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duramed Research

INDUSTRY